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Summary
The survival of motor neurons (SMN) protein, product
of the disease gene of the common neurodegenera-
tive disease spinal muscular atrophy, is part of the
large multiprotein “SMN complex.” The SMN complex
functions as an assembly machine for small nuclear
ribonucleoproteins (snRNPs)—the major components
of the spliceosome. Here, we report the crystal struc-
ture of two components of the human SMN complex,
Gemin6 and Gemin7. Although Gemin6 and Gemin7
have no significant sequence similarity with Sm pro-
teins, both adopt canonical Sm folds. Moreover,
Gemin6 and Gemin7 exist as a heterodimer, and in-
teract with each other via an interface similar to that
which mediates interactions among the Sm proteins.
Together with binding experiments that show that the
Gemin6/Gemin7 complex binds to Sm proteins, these
findings provide a framework for considering how the
SMN complex, with Gemin6 and Gemin7 as tools,
might organize Sm proteins for formation of Sm rings
on snRNA targets.
Introduction
The survival of motor neurons (SMN) complex is a
multiprotein machine that plays a central role in the bio-
genesis of ribonucleoprotein complexes (RNPs), in-
cluding spliceosomal small nuclear RNPs (snRNPs)
(Fischer et al., 1997; Meister et al., 2001; Pellizzoni et
al., 1998) and, possibly, small nucleolar RNPs (snoRNPs)
(Jones et al., 2001; Pellizzoni et al., 2001a), hetero-
geneous nuclear RNPs (hnRNPs) (Mourelatos et al.,
2001), and transcriptosomes (Pellizzoni et al., 2001b).
The SMN complex is located both in the cytoplasm of
cells, where immunofluorescence studies indicate a dif-
fuse distribution, and in the nucleus, where it is highly
concentrated in nuclear bodies termed gems (Liu and
Dreyfuss, 1996; Liu et al., 1997). Consistent with its crit-
ical role in the biogenesis of snRNPs, the SMN protein
is essential for viability in all eukaryotic organisms
tested thus far, including mouse, chicken, fly, worm,
and fission yeast (Hannus et al., 2000; Miguel-Aliaga et
al., 1999, 2000; Owen et al., 2000; Paushkin et al., 2000;
Schrank et al., 1997; Wang and Dreyfuss, 2001). Re-
duced levels of SMN as a result of deletions or loss-of-
function mutations in the SMN gene cause spinal mus-
cular atrophy (SMA), a common neurodegenerative
disease characterized by the degeneration of motor*Correspondence: vanduyne@mail.med.upenn.eduneurons of the spinal cord (Lefebvre et al., 1995). SMA
is the leading genetic cause of infant mortality, affecting
w1 in 6000 newborns (Melki, 1997).
In addition to SMN, the SMN complex contains sev-
eral proteins called Gemins2–7 (Gubitz et al., 2004;
Paushkin et al., 2002). Of these, Gemin3 contains a
DEAD-box RNA helicase motif (Charroux et al., 1999)
and Gemin5 contains multiple WD repeats (Gubitz et
al., 2002), but the remaining components of the SMN
complex contain no recognizable domains that could
provide insight into their functional roles. Gemin2,
Gemin3, and Gemin5 interact directly with SMN,
whereas Gemin4 is recruited to the complex through its
interaction with Gemin3 (Charroux et al., 1999, 2000;
Gubitz et al., 2002; Liu et al., 1997). Similarly, Gemin6
associates with the SMN complex indirectly through
Gemin7, which binds to SMN through its N-terminal 30
amino acid residues (Baccon et al., 2002; Pellizzoni et
al., 2002a).
Although several studies suggest a function for the
SMN complex in the nucleus (Pellizzoni et al., 2001b),
its role in the biogenesis of snRNPs in the cytoplasm is
best understood. The major snRNPs (named by their
snRNA components U1, U2, U4/U6, and U5) are essen-
tial components of the spliceosome, a dynamic protein/
RNA machine that mediates the nuclear excision of in-
trons from pre-mRNA. Each snRNP consists of one U
snRNA molecule, a core composed of seven highly
conserved Sm proteins, and several snRNP-specific
proteins (Will and Luhrmann, 2001). With the exception
of U6, the major U snRNAs are exported to the cyto-
plasm where the Sm protein core is assembled on the
Sm site of the U snRNA and the 5#-cap is hypermeth-
ylated (Mattaj and De Robertis, 1985). The partially as-
sembled snRNP is believed to contain a heptameric
ring of Sm proteins encircling the Sm site, which is a
short, single-stranded, uridine-rich sequence flanked
by two RNA stem-loop structures (Will and Luhrmann,
2001). The assembly of the Sm core is required for hy-
permethylation of the cap structure, and provides a
nuclear localization signal for import of mature snRNP
back into the nucleus (Kleinschmidt et al., 1989; Raker
et al., 1996, 1999; Sumpter et al., 1992).
The Sm core readily assembles on U snRNAs in vitro
in the absence of ATP when purified RNAs and total
snRNP proteins are mixed (Raker et al., 1996, 1999;
Sumpter et al., 1992). However, this process requires
ATP hydrolysis in HeLa cell and Xenopus laevis egg ex-
tracts (Kleinschmidt et al., 1989; Meister et al., 2001).
In vitro, the SMN complex has been shown to mediate
the assembly of Sm proteins on the Sm site of U
snRNAs by a mechanism that requires ATP binding, but
not ATP hydrolysis (Pellizzoni et al., 2002b). In this pro-
cess, the SMN complex is thought to function as an
assembly chaperone that prevents illicit assembly of
the Sm proteins on irrelevant uridine-rich RNAs (Pelliz-
zoni et al., 2002b).
As part of an overall effort to study the structure and
function of the SMN complex, we are investigating the
structures and biochemical properties of individual pro-
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884teins and stable subcomplexes in this system. Here we e
lreport the crystal structure of the human Gemin6/
Gemin7 (hereafter referred to as Gemin6/7) complex. t
fAlthough neither protein displays any significant se-
quence homology to Sm protein family members, the m
tstructure reveals that Gemin6 and Gemin7 both contain
Sm-like folds and that the Gemin6/7 interface is similar s
ato the interfaces observed between Sm proteins. We
also show that the Gemin6/7 heterodimer is competent C
rto bind and perhaps to organize Sm proteins. Together,
the structural and biochemical data indicate that t
iGemin6/7 may participate in formation of higher order
complexes with Sm or Sm-like proteins and could func- t




Secondary structure prediction methods indicated that O
Gthe N-terminal 30 residues of Gemin7 that have been
shown to be required for interaction with SMN are likely s
ato be unstructured in the free Gemin6/7 complex (the
domain structures of Gemin6 and Gemin7 are shown n
tschematically in Figure 1A). These residues were there-
fore removed from the constructs used for crystallo- u
tgraphic studies. Limited trypsin proteolysis of the
Gemin6/7 complex, coupled with MALDI-TOF mass a
fspectral analysis and N-terminus sequencing of tryp-
tic fragments also identified a domain boundary in t
oGemin6, near residue 92 (data not shown). Coexpres-
sion and copurification of Gemin6 (residues 1–92) with t
sGemin7 (residues 31–131) confirmed that the N-ter-
minal domain of Gemin6 was both necessary and suffi- t
Ccient for tight association with Gemin7. However, only
the full length Gemin6/Gemin7 (residues 31–131) com-
tplex formed diffraction quality crystals.
Crystals of the Gemin6/7 complex that diffracted to (
G2.8 Å resolution were produced by vapor diffusion, andFigure 1. Domain Structure and Electron
Density for the Gemin6/7 Complex at the β4-
β5 Interface
(A) Schematic of domain organization in
Gemin6 and Gemin7. The region on Gemin7
required for interaction with SMN and the
domains that interact with one another in
Gemin6 and Gemin7 are indicated.
(B) Experimental electron density map for
crystal form II from Solve/Resolve phasing at
2.8 Å resolution, contoured at 1.5 σ. Gemin6
is colored green (right half) and Gemin7 is
orange (left half).
(C) σA-weighted 2Fo − Fc electron density for
the final refined structure in crystal form I at
2 Å resolution, contoured at 1.5 σ. The orien-
tation and coloring of the indicated β strands
is the same as that shown in (A).xperimental phases were determined from multiwave-
ength anomalous scattering data using SeMet-substi-
uted Gemin6 and Gemin7. A second crystal form dif-
racted to higher resolution, but was not amenable to
ultiwavelength phasing using SeMet-substituted pro-
eins. We therefore used molecular replacement to po-
ition Gemin6/7 in the higher resolution crystal form
nd refined the resulting structure to 2.0 Å resolution.
rystallographic data and the results of phasing and
efinement are summarized in Table 1, and representa-
ive electron density of the Gemin6/7 structure is shown
n Figure 1B. There are two Gemin6/7 heterodimers in
he asymmetric unit of both crystal forms, and all four
f the independent heterodimer structures are similar,
ith pairwise rms deviations ranging from 0.3–1.1 Å for
uperposition of Cα atoms, excluding the variable β3-
4 loop region (discussed below).
verall Structure of the Gemin6/Gemin7 Complex
emin6 and Gemin7 have similar folds, with a five-
tranded bent β sheet flanked by α helices (Figures 2A
nd 2B). The two β sheets in the heterodimer are con-
ected via β4 of Gemin6 and β5 of Gemin7, resulting in
he formation of a continuous 10-stranded β sheet (Fig-
re 2C). The longer N-terminal helix of Gemin7 packs
ightly into a hydrophobic pocket formed by α1, β2-β4,
nd α2 of Gemin6. This hydrophobic interface is
lanked by a network of hydrogen bonds formed be-
ween α1 side chains in Gemin7 and pocket residues
f Gemin6. Overall, the Gemin6/7 interface buries a to-
al of 2577 Å2 solvent-accessible surface area with a
hape complementarity index of 0.77, which is consis-
ent with a highly specific interaction (Lawrence and
olman, 1993).
The two independent Gemin6/7 heterodimers in-
eract in the crystal to form a two-fold-symmetric
Gemin6/7)2 heterotetramer via the β3-β4 loop of
emin6 (Figure 2D). The β3-β4 hairpin extends from the
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885Table 1. Crystallographic Data
Diffraction Data
Crystal form I II
Space group P42212 P6122
Cell constants (Å) a = 136.0, c = 81.5 a = 107.1, c = 289.1
Native SeMet λ1 SeMet λ2 SeMet λ3
Resolution (Å) 50–2.0 50–2.8 50–2.8 50–2.8
Completeness (%) 95.6 (66.0) 95.4 (65.2) 95.7 (67.4) 95.2 (64.3)
Redundancya 32.4 (4.7) 28.6 (3.9) 28.5 (3.9) 28.3 (4.0)
<I/σ> 36.8 (3.7) 24.0 (3.5) 23.7 (3.5) 23.9 (3.4)
Rsym (%)b 7.2 (31) 7.8 (26.3) 7.7 (26.4) 7.8 (27.6)
SOLVE Phasing
Resolution 2.8 Å
Overall figure of merit 0.55
Overall Z score 36.3
Refinement
Resolution 2.0 Å
Rworking (%) 21.7 (27)
Rfree (%) 25.2 (33)
Average B (Å2) 32.5
Rms bonds (Å) 0.019
Rms angles (°) 1.283
Values in parentheses are for the highest resolution shell. Wavelengths are λ1 = 0.97974Å (inflection), λ2 = 0.97961Å (peak), and λ3 =
0.97190Å (remote).
a Redundancy = the number of observations/the number of unique reflections.
b Rsym = Σh|Ih − <I>h|/ΣIh, where <I>h is the average intensity over symmetry equivalents.lattices. To establish whether the higher order oligomer erodimer model (that does not dissociate), with no indi-
Figure 2. Structure of the Gemin6/7 Complex
(A) Ribbon diagram of the Gemin6/7 com-
plex, with Gemin6 and Gemin7 colored green
and orange, respectively. Residues forming
polar interactions between Gemin7-α1 and
Gemin6 are drawn as sticks. The N-terminal
30 residues of Gemin7 are shown schemati-
cally as a dashed orange line.
(B) Orthogonal view to that shown in (A), but
with residues forming hydrophobic interac-
tions between Gemin7-α1 and Gemin6 drawn
as sticks.
(C) Closeup of the β4-β5 interface between
Gemin6 and Gemin7 that forms an extended
β sheet.
(D) The Gemin6/7 heterotetramer present in
both crystal forms of the Gemin6/7 complex.
The dimerization interface involves the β3-β4
region and the symmetry dyad is indicated.main body of each heterodimer, exposing side chains
that can self-associate primarily via polar and electro-
static interactions. This interface buries a total of 861
Å2 solvent-accessible surface area and the same
heterotetramer is observed in both crystal forms, de-
spite the fact that crystal packing is different in the twoobserved in the crystals is also present in solution, we
analyzed the Gemin6/7 complex at three different con-
centrations using sedimentation equilibrium ultracen-
trifugation. At complex concentrations ranging from 9
to 123 M, radial distributions measured at equilibrium
for three speeds were fit well by a single-species het-
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886cation of heterotetramer formation (see Experimental c
aProcedures). Although the centrifugation data indicates
sthat the Gemin6/7 heterodimer does not self-associate
Sto any significant extent in the absence of other pro-
vteins, we cannot rule out a role for this interaction in
bthe context of the SMN complex, where higher order
toligomerization via SMN is known to play an important
Tfunctional role (Pellizzoni et al., 1999). In this case,
iGemin6/7 may be present in multiple copies, where the
mweak affinity interaction observed here in the Gemin6/7
Scrystals could be functionally relevant.
sGel electrophoresis analysis of dissolved crystals
fconfirmed that full-length Gemin6 was present in both
Gemin6/7 complex crystal forms, but electron density
hfor the C-terminal domain of Gemin6 (residues 87–167)
tis not sufficiently well defined in either crystal form to
Sallow tracing of the polypeptide chain. Small helical
csegments could be identified in difference electron
pdensity maps of crystal form II, but the sequence could
Gnot be assigned, and connectivity to the corresponding
sN-terminal domain could not be established. We be-
Alieve that the missing C-terminal domain of Gemin6 is
bfolded in the Gemin6/7 crystals because the isolated
Adomain can be overexpressed and purified and is resis-
atant to mild trypsin proteolysis (data not shown).
AStraightforward crystallographic refinement to the re-
asiduals shown in Table 1 supports the conclusion that
Sthe Gemin6 C-terminal domain is disordered and, there-
cfore, does not contribute to the high-resolution diffrac-
tion data. Although unexpected, the disordering of an
aentire domain in a high-resolution crystal structure has
fbeen observed (for example, see Rice and Steitz, 1994).
lInterestingly, N-terminal sequencing of limited proteoly-
tsis products of the Gemin6/7 complex showed that
htrypsin cleaves Gemin6 after Lys92 to produce N-ter-
tminal and C-terminal domains with a boundary that
mclosely matches that observed in the crystals.
e
IGemin6 and Gemin7 Resemble Sm Proteins h
Primary amino acid sequence analyses of Gemin6 and h
Gemin7 did not indicate significant homology with S
known proteins in the databases (Baccon et al., 2002; C
Pellizzoni et al., 2002a). However, the Gemin6/7 struc- c
ture reveals that both Gemin6 and Gemin7 contain folds 1
that are similar to those observed in the spliceosomal a
Sm proteins. The closest matches to proteins with o
known three-dimensional structure using DALI (Holm 4
and Sander, 1993) are the bacterial Sm-like Hfq (Schu- t
macher et al., 2002), human SmB, SmD3, SmD1, and N
SmD2 (Kambach et al., 1999), and archaeal Sm (Mura t
et al., 2001; Toro et al., 2001) proteins. The Sm proteins i
are evolutionarily conserved, with homologs from bac- i
teria to humans, and, like Gemin6 and Gemin7, they s
contain an N-terminal helix followed by a 5-stranded, 1
highly bent antiparallel β sheet. This protein family is D
also characterized by two sequence motifs, Sm1 and
Sm2, which are separated by a sequence of variable n
length (Hermann et al., 1995; Seraphin, 1995). An align- N
ment of Gemin6 and Gemin7 with the human Sm pro- (
teins is shown in Figure 3. t
Among the human Sm proteins, Gemin6 is most sim- m
ilar in structure to SmD1 (PDB entry 1B34), with an rms i
pdeviation of 1.7 Å over 58 α-carbons, and Gemin7 mostlosely superimposes with SmB (PDB entry 1D3B), with
n rms deviation of 1.9 Å over 60 α-carbons. A repre-
entative superposition of Gemin6, Gemin7, and human
mD3 is shown in Figure 4A. The primary source of
ariation among the human Sm protein structures and
etween Gemin6/7 and the Sm proteins exists in the
wo terminal segments and in the variable β3-β4 region.
he α1-helix in Gemin7 is also substantially longer than
n either the Sm proteins or in Gemin6. Of the four hu-
an Sm proteins with experimental structures, only
mD1 has a C-terminal helix corresponding to that ob-
erved in Gemin6, but the helices are oriented dif-
erently in the two cases (data not shown).
Structure-based sequence alignment of the seven
uman Sm proteins with Gemin6 and Gemin7 indicates
hat strongly conserved amino acids in the Sm1 and
m2 motifs, which are important for the Sm fold, are
onserved in Gemin6 and Gemin7 (Figure 3). For exam-
le, in human SmB/B#, Asn39 hydrogen bonds with
ly74 and Asp35, linking the C-terminal segments of
trands β2 and β4 with the N terminus of β3. In Gemin6,
sn43, Gly62, and Asp38 form an identical hydrogen
onding network. Similarly, SmD3 residues Asp37,
sn40, and Tyr62 and Gemin7 residues Asp96, Asn101,
nd Tyr103 form the same hydrogen bonding patterns.
s expected, Gemin6 and Gemin7 also share the char-
cteristic pattern of hydrophobic residues found in the
m1 and Sm2 motifs, although the identities of these
ore packing residues are not strongly conserved.
The structural similarity between Gemin6 and Gemin7
nd the Sm proteins also extends to the interface
ormed in the Gemin6/7 heterodimer (Figure 2C). Sm-
ike proteins display a propensity to oligomerize with
hemselves or with other Sm proteins by formation of a
ead-to-tail continuous β sheet via interactions be-
ween edge strands (β4 and β5) of the interacting do-
ains (Collins et al., 2003; Kambach et al., 1999; Mura
t al., 2001; Schumacher et al., 2002; Toro et al., 2001).
n the absence of U snRNAs, the seven Sm proteins
ave been shown to preferentially form three stable
eteromeric subcomplexes, SmD3/B, SmD1/D2, and
mF/E/G (Lehmeier et al., 1990; Raker et al., 1996).
rystal structures for the D3/B and D1/D2 Sm domain
ocomplexes have been reported (Kambach et al.,
999), and Gemin6/7 superimposes on these structures
s a heterodimer reasonably well, with rms deviations
f 2.5 and 3.3 Å, respectively, over Cα atoms (Figure
B). The largest difference between the Gemin6/7 and
he SmB/D3 or SmD1/D2 interfaces involves the longer
-terminal helix found in Gemin7, which allows forma-
ion of a more substantial interaction with Gemin6 than
s observed between the human Sm proteins. This more
ntimate Gemin6/7 interface is reflected in the higher
hape complementarity index (Lawrence and Colman,
993) for Gemin6/7 (0.77) compared to those for SmB/
3 (0.72) and SmD1/D2 (0.73).
A structural similarity to Sm proteins has also been
oted for the SMN tudor domain, which lacks the
-terminal helix and fifth β strand found in the Sm folds
Selenko et al., 2001). Unlike the Sm proteins, however,
he SMN tudor domain is monomeric in solution, which
ay reflect its inability to form a homomeric β4-β5
nterface. In principle, the tudor domain could bind to
roteins with Sm folds via the β4 edge of its β sheet to
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887Figure 3. Sequence Alignment of Gemin6, Gemin7, and the Human Sm Proteins
The seven human Sm proteins are aligned based on sequence homology, with shaded regions indicatingR57% identity among the sequences
shown. Strictly conserved Gly and Asn are indicated with arrowheads. Sm1 and Sm2 motifs are boxed. Gemin6 and Gemin7 sequences are
aligned with the human Sm protein sequences based on structural similarity. Secondary structure elements of Gemin6 and Gemin7 are shown
above the sequences.labeled Sm proteins were incubated with Gemin6/7faces on both Gemin6 and Gemin7 that could be used
Figure 4. Superposition of Gemin6, Gemin7,
and the Human Sm Proteins
(A) Superposition of Cα backbones of human
SmD3 (black), Gemin6 (green), and Gemin7
(orange). The variable β3-β4 regions are indi-
cated.
(B) Superposition of the Gemin6/7 complex
(green and orange) with the human SmD3/B
complex (black).form interfaces that resemble those discussed above
for Sm proteins and for Gemin6/7. So far, there is no
evidence for this type of “β4-β5” interaction between
the SMN tudor domain and Sm proteins. Instead, the
SMN tudor domain has been shown to interact with the
RG-rich tails in SmB, SmD1, and SmD3, and symmetri-
cal dimethylation of arginine residues in these tails is
important for high affinity binding (Brahms et al., 2001;
Selenko et al., 2001).
The Gemin6/Gemin7 Complex Binds Sm Proteins
Both Gemin6 and Gemin7 have been shown previously
to interact in vitro with the human Sm proteins, and
the similarity between Gemin6/7 and the Sm proteins
immediately suggests how they are likely to interact. In
principle, however, there are two distinct binding sur-to bind Sm proteins (Figure 5). The β5 surface of
Gemin6 and the β4 surface of Gemin7 are both exposed
and available for interaction with Sm proteins in the
Gemin6/7 complex, whereas the β4 surface of Gemin6
and β5 surface of Gemin7 would only be available to
interact with Sm proteins if the Gemin6/7 complex were
disrupted. If Sm proteins bind only to the β4 surface of
Gemin6 and β5 surface of Gemin7 when the proteins
are assayed independently, then we would expect Sm
binding to Gemin6 and Gemin7 to be abolished upon
Gemin6/7 heterodimer formation.
To determine if the Gemin6/7 complex is capable of
binding Sm proteins, we carried out in vitro binding ex-
periments comparing Sm proteins binding to Gemin6
alone with Sm proteins binding to the Gemin6/7 com-


















cFigure 5. Speculative Model for Gemin6/7 Complex Interactions
iwith Sm Proteins
aSmD3 (yellow) was docked to either end of the Gemin6/7 complex
(green and gold), assuming that the SmD3/Gemin6 and SmD3/
Gemin7 interfaces would be similar to those observed in SmD3/
SmB and SmD1/SmD2. No significant steric clashes are present in D
the modeled interfaces. Three additional Sm proteins can be read-
ily added to the model to form a closed heptameric ring, as pre- B
viously shown for the Sm proteins (Kambach et al., 1999).
a
p
wcomplex immobilized on glutathione agarose beads via
the GST-Gemin6 fusion. After extensive washing, bound b
sproteins were stripped from the beads and analyzed by
SDS-PAGE. As shown in Figure 6, the Gemin6/7 com- r
cplex binds with highest affinity to Sm B, SmD2, SmD3,
and SmE. Only weak binding was observed for SmD1, F
sSmF, and SmG, and no binding was observed for immo-
bilized GST alone (data not shown). Because the h
2tandem affinity procedure used here to purify the
Gemin6/7 heterodimer provides a stoichiometric 1:1 f
Icomplex, and because we have so far not observed any
dissociation of the Gemin6/7 complex under stringent i
rwashing conditions, we are confident that the interac-
tions observed with Sm proteins are with the intact a
cGemin6/7 complex and not with immobilized Gemin6
that has lost Gemin7. These results are consistent with r
a model in which the Gemin6/7 complex can bind Sm
proteins via the exposed β5 and β4 strands of Gemin6 a
pand Gemin7, respectively (Figure 5).
The binding of Sm proteins to the Gemin6/7 complex et al., 2001; Meister and Fischer, 2002) and specific re-
Figure 6. The Gemin6/7 Complex Binds Sm
Proteins
The indicated Sm proteins were produced
individually by in vitro transcription and
translation in rabbit reticulocyte lysates in
the presence of [35S]Methionine. In vitro-
translated proteins were incubated with 2 g
of purified recombinant GST-Gemin6 (middle
panel) or with GST-Gemin6/Gemin7 complex
(right panel) coupled to glutathione beads.
After extensive washing, bound proteins
were resolved by SDS-PAGE and visualized
by fluorography. Input (left panel) represents
5% of the labeled protein used for binding.
Positions of molecular weight markers are indicated and proteolysis products that we believe to be Sm core domains are indicated by
asterisks. The fragments of SmD2, SmD3, and SmE also bind to Gemin6 and Gemin6/7 and may be present at higher concentrations in the
middle and right panels relative to the input panel because of continued proteolysis during binding and washing. In some cases, the fragments
may also bind with enhanced affinity to Gemin6 or Gemin6/7.hows a similar pattern of relative affinities as that ob-
erved for Gemin6 alone, although the binding is some-
hat weaker for the Gemin6/7 complex. This difference
n binding affinities suggests that the β4 surface of
emin6 may bind efficiently to Sm proteins in the ab-
ence of Gemin7, leading to a higher overall affinity
han for the Gemin6/7 complex. It is also possible that
he N terminus of Gemin7 modulates the binding to Sm
roteins through the β5 interface of Gemin6 (see Figure
). Interestingly, even the weakest binding observed be-
ween Sm proteins and Gemin6 and Gemin6/7 complex
n this experiment may be relevant in vivo. Coexpres-
ion experiments in bacteria have revealed that GST-
emin6 forms a complex with hexahistidine-tagged
mD1 (which binds weakest among the Sm proteins
o Gemin6 and Gemin6/7) when the two proteins are
oexpressed, and the resulting Gemin6/SmD1 complex
s stable through both glutathione agarose and Ni-NTA
garose purification steps (data not shown).
iscussion
ased on the crystal structures of the human Sm D3/B
nd Sm D1/D2 complexes, Nagai and colleagues pro-
osed that human Sm proteins form heptameric rings
hen assembled on the Sm sites of U snRNAs (Kam-
ach et al., 1999). This model is supported by negative-
tain electron microscopy data of U1 snRNP, which
eveals a doughnut-shaped core that could readily ac-
ommodate the seven Sm proteins (Stark et al., 2001).
urther support comes from recently described crystal
tructures of an archaeal Sm-like protein that forms a
omoheptameric ring (Mura et al., 2001; Toro et al.,
001) and the bacterial Sm-like protein Hfq, which
orms a homohexameric ring (Schumacher et al., 2002).
n this context, the role of the SMN complex in mediat-
ng spliceosomal snRNPs assembly is to promote Sm
ing formation on Sm sites of the appropriate snRNAs,
nd to disallow assembly on irrelevant RNA molecules
ontaining uridine-rich stretches that would otherwise
esemble Sm sites.
Two important features of the SMN-mediated snRNP
ssembly process in vivo are the sequestration of Sm
roteins by components of the methylosome (Friesen
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889cruitment of snRNA molecules by the SMN complex
(Yong et al., 2004a). The current view of this process is
that Sm proteins are symmetrically dimethylated in their
RG-rich repeat regions by the methylosome, which in
turn allows them to be recruited to the SMN complex
and assembled specifically onto recruited snRNA Sm
sites (Meister et al., 2002; Yong et al., 2004b). The roles
of individual protein components of the SMN complex
have not yet been identified in terms of this assembly
process, but Sm protein binding and organization,
snRNA recruitment, and Sm loading onto the RNA
clearly must be accommodated in any model for under-
standing the mechanism of ATP-dependent assembly.
An intriguing possibility is that Gemin6 and Gemin7
participate in binding and organizing Sm proteins in
preparation for snRNP assembly. The model shown in
Figure 5 implies that Gemin6/7 could serve as an Sm
dimer surrogate, binding to individual Sm proteins or to
Sm subcomplexes to form a partial ring in preparation
for snRNA loading. This Gemin6/7/Sm assembly could
be an open ring (as shown in Figure 5) or a closed hep-
tameric ring, with Gemin6/7 acting as a temporary Sm
dimer. Interestingly, previous work has shown that
snRNP core assembly occurs in a distinct, stepwise
manner, with SmD1, D2, E, F, and G assembling on the
U snRNA Sm site first to form a stable subcore, fol-
lowed by addition of SmD3/B (Andersen and Zieve,
1991; Raker et al., 1996). The structural comparison of
Gemin6/7 with Sm protein heterodimers revealed clos-
est similarity with SmD3/B, supporting the idea that the
Sm domains of Gemin6/7 could function as an SmD3/B
surrogate during snRNP assembly. Other components
of the SMN complex clearly must also contribute to the
process of Sm recruitment from the methylosome,
which involves recognition of symmetrically dimethyl-
ated arginine residues in the RG-rich tails of a subset
of the Sm proteins.
An alternative interpretation for the role of Gemin6
and 7 in the SMN complex is that Gemin6 and 7 are
Sm-like proteins that are components of a yet-to-be-
identified RNP complex. In this case, one might con-
clude that Gemin6/7 copurifies with the SMN complex
because it is an RNP assembly substrate, rather than
an assembly factor. Although this possibility cannot be
entirely ruled out, we do not favor this viewpoint be-
cause Gemin6 and 7 remain associated with the SMN
complex at very high stringency—conditions that com-
pletely remove the Sm proteins. Furthermore, immuno-
fluorescence microscopy of Gemin6 and 7 in HeLa cells
indicates that both proteins colocalize with SMN, with
a characteristic diffuse pattern in the cytosol and
discreet localization to gems in the nucleus (Baccon et
al., 2002; Pellizzoni et al., 2002a). Other components of
the SMN complex (SMN and Gemins 2–5) show a sim-
ilar colocalization pattern (Liu et al., 1997; Charroux et
al., 1999; Gubitz et al., 2002), but Sm proteins and other
likely assembly substrates known to interact with SMN,
such as GAR1 and fibrillarin, do not show this charac-
teristic cellular colocalization.
The model for Gemin6/7-Sm protein interactions
shown in Figure 5 is consistent with what is known
about the oligomeric properties of Sm-like proteins,
with the types of interactions shown to exist between
human Sm proteins, and with the ability of Gemin6 and7 to form Sm-like interfaces. However, a functional role
for Gemin6/7 participating in formation of a ring (or par-
tial ring) of Sm proteins is at this point still speculative.
An alternative or additional mode of interaction be-
tween Gemin6 and 7 and Sm proteins could involve the
RG-rich C-terminal tails of SmB, SmD3, and SmD1,
which are known to be important in SMN-Sm protein
interactions (Friesen and Dreyfuss, 2000; Brahms et al.,
2001). Given the structural similarity between the SMN
tudor domain, the Sm proteins, and Gemin6/7, it is
plausible that such an interaction could also play a role
in Gemin6/7 interacting with Sm proteins. However, we
believe it unlikely that the RG-rich tails of Sm proteins
play a major role in binding to Gemin6/7 for several
reasons. First, neither Gemin6 nor Gemin7 contain an
obvious aromatic binding pocket or acidic surface that
could correspond to that observed in the SMN tudor
domain and which is implicated in interacting with
sDMA residues (Sprangers et al., 2003). Second, the
binding preferences of Sm proteins to both Gemin6 and
Gemin6/7 show no correlation with the presence or ab-
sence of tails that would presumably be methylated to
some extent in the eukaryotic extracts used in produc-
ing Sm proteins by in vitro translation. Indeed, SmD2
and SmE bind to Gemin6 and to Gemin6/7 with the
highest affinity, yet neither has an RG-rich tail and nei-
ther is known to be methylated in vivo. Alternatively,
SmD1 does have an RG-rich C-terminal tail, yet binds
most weakly to both Gemin6 and Gemin6/7. As de-
scribed above, bacterially expressed SmD1 does form
a stable complex with Gemin6, but SmD1 is not methyl-
ated in bacteria (Brahms et al., 2000). Although we can-
not rule out a possible role for the RG-rich tails of Sm
proteins in interacting with Gemin6/7, our current data
indicates that this is not likely to be the primary bind-
ing mechanism.
There is still a considerable gap in our understanding
of how the SMN complex assembles snRNPs on a de-
tailed molecular level. Work toward achieving this goal
would be greatly aided by structural models of the in-
tact SMN complex or of each individual component of
the complex, along with in vitro assays of snRNP as-
sembly that would facilitate testing of mechanistic
hypotheses. The crystal structure of the Gemin6/7
complex reported here is an important step toward
building a structural model for this system, and to-
gether with NMR and crystallographic data for the SMN
tudor domain (Selenko et al., 2001; Sprangers et al.,
2003), represents the only structural data available at
this point for the SMN complex. Major progress has
also been made recently in the development of in vitro
assays for snRNP assembly, where the SMN complex
is either derived from cellular extracts or is purified from
HeLa cells (Meister et al., 2001; Pellizzoni et al., 2002b).
Indeed, preliminary experiments indicate that extracts
from cells in which Gemin6 protein levels have been
reduced by small interfering RNA molecules are defi-
cient in snRNP assembly (G.D., unpublished data).
The discovery that Gemin6 and 7 have Sm fold struc-
tures indicates that this protein superfamily is larger
than previously thought and includes proteins that do
not contain canonical Sm motifs (Seraphin, 1995; Her-
mann et al., 1995), including the SMN tudor domain. It
is intriguing that the SMN complex might take advan-
Structure
890dtage of the structures and oligomeric properties of Sm
tsuperfamily proteins by using an Sm-like assembly
tfactor to interact with and organize Sm protein sub-
1
strates. With continuing work toward developing a m
structural model for the SMN complex and improved T
cassays for snRNP assembly, a molecular understanding




IExpression and Purification of the Gemin6/7 Complex
HA cleavable glutathione-S-transferase (GST) fusion of full length
lGemin6 was coexpressed with hexahistidine-tagged Gemin7 (resi-
fdues 31–131) using compatible T7 expression plasmids in strain
iBL21(DE3) at 17°C. In both cases, the coding regions were sub-
wcloned into vectors containing the respective fusion tags followed
pby cleavage sites for tobacco etch virus (TEV) protease (Parks et
Cal., 1994). After purification of the complex on glutathione-agarose
dresin (Sigma) followed by TALON resin (BD Biosciences), both the
tGST and hexahistidine tags were removed by overnight dialysis at
e4°C in the presence of TEV protease. The Gemin6/7 complex was
bfurther purified by MonoQ anion-exchange chromatography (Phar-
cmacia), followed by size-exclusion chromatography on a Bio-Rad
HSEC-250 column. The SEC-250 elution time indicated an apparent
bmolecular weight of 30 kDa relative to calibration with globular pro-
mtein standards. The Gemin6/7 complex was concentrated to 60 mg/
mml in 10 mM sodium HEPES, pH 7.0, 5 mM DTT, using Centricon
mYM-10 devices (Millipore). Selenomethionine was incorporated into
bthe Gemin6/7 complex by expression in strain B834(DE3) using




WSedimentation equilibrium experiments were performed at 20°C
Dwith an XL-A analytical ultracentrifuge (Beckman) and a Ti An60
Srotor with six-channel charcoal-filled epon centerpieces and quartz
vwindows. The Gemin6/7 complex (9.1 M, 24.8 M, and 122.6 M)
fwas centrifuged at 20,000, 25,000 and 30,000 rpm, respectively, for
a14 hr, at which time equilibrium was established. Radial absorption
Hscan data at 281 nm, 291 nm, and 297 nm, respectively, for each
fof the three concentrations could be fit well by a single species
imodel, with an experimental molecular weight of 29.3 kDa (the puri-
Hfied Gemin6/7 complex calculated molecular weight is 30.2 kDa)
using ULTRASCAN data analysis software (Demeler, 2003).
R
RCrystallization, Data Collection, and Structure Determination
ACrystals of the Gemin6/7 complex were grown at 18°C from hang-
Ping drops at a concentration of 20 mg/ml in the presence of 100
mM sodium acetate, pH 4.7, and 12% 2-methyl-2,4-pentanediol
(MPD). Crystals were transferred into a cryoprotectant solution R
containing 100 mM sodium acetate, pH 4.7, 25% MPD before being
flash-frozen in liquid nitrogen prior to data collection at 100 K. Two A
crystal forms were obtained from this condition: form I diffracted t
to higher resolution, but only form II yielded diffraction-quality crys- B
tals using SeMet-containing proteins. The structure was therefore G
determined initially in crystal form II using multiwavelength phasing c
from SeMet proteins, and was later refined to high resolution using 2
data from crystal form I. Both forms contain two Gemin6/7 hetero-
B
dimers in the crystallographic asymmetric unit.
a
Native data for crystal form I and multiwavelength anomalous
t
scattering data for crystal form II were measured at the Advanced
m
Light Source Beamline 8.2.2, using an ADSC Quantum 315 CCD
t
detector. Diffraction data were processed using the HKL package
B(Otwinowski and Minor, 1997). Multiwavelength phasing (based on
m11 ordered Se sites) and phase improvement were performed using
sSOLVE/RESOLVE (Terwilliger, 2000). The experimental and solvent-
tflattened electron density maps were of high quality, and all four
protein chains were readily traced, except that the C-terminal 83 C
Mresidues of Gemin6 did not have interpretable electron density. Iter-
ative rounds of model building with O (Jones et al., 1991) and re- i
ifinement with REFMAC5 (Murshudov et al., 1999) resulted in a well-efined structure that was used as a molecular replacement model
o compute starting phases for crystal form I. Both heterodimers in
he asymmetric unit were readily positioned using AMORE (Navaza,
994), and REFMAC5 refinement combined with model adjust-
ents rapidly converged to yield the statistics shown in Table 1.
he final refined model includes residues 1–86 for both Gemin6
hains, residues 47–131 for one Gemin7 chain, residues 49–131 for
he second Gemin7 chain, and 108 solvent molecules modeled as
ater. All residues have allowed values of (f,ψ) backbone dihedral
ngles. Structural illustrations and electron density (Figures 1, 2, 4,
nd 5) were prepared with Pymol (Delano, 2002).
n Vitro Protein Binding Assays
is6-tagged Gemin7 (residues 31–131) and GST-Gemin6 (full
ength) were coexpressed as described above. The complex was
irst purified on TALON resin to remove any excess Gemin6 before
t was incubated with glutathione-agarose beads (Sigma) and
ashed according to the manufacturer’s protocol. Protein com-
lexes bound to glutathione-agarose beads were quantified by
oomassie staining of SDS-PAGE gels relative to protein stan-
ards. Human Sm proteins were produced by in vitro transcription/
ranslation using rabbit reticulocyte lysate (Promega) in the pres-
nce of [35S]methionine according to the vendor’s instructions. For
inding experiments, 10 l of in vitro-translated products were in-
ubated with 2 g of either GST, GST-Gemin6, or GST-Gemin6/
is6-Gemin7 (residues 31–131) complex bound to glutathione
eads in binding buffer (50 mM Tris-HCl, pH 7.4, 2 mM EDTA, 200
M NaCl, 0.1% NP40, Roche protease inhibitor cocktail), and
ixed for 1 hr at 4°C. Beads were then washed five times with 0.5
l binding buffer. Bound proteins were eluted in SDS-PAGE sample
uffer, resolved by SDS-PAGE, and detected by fluorography.
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